[Salidroside improves pulmonary fibrosis by down-regulation of cathepsin B and NF-κBp65 in rats].
Zhong Nan Da Xue Xue Bao Yi Xue Ban
; 42(2): 128-133, 2017 Feb 28.
Article
em Zh
| MEDLINE
| ID: mdl-28255112
ABSTRACT
OBJECTIVE:
To investigate the mechanism of salidroside in improvement of pulmonary fibrosis in rats.â©Methods:
SD rats were subjected to 6 groups a blank group, a model group, a pirfenidone group, a high-dose salidroside group, a middle-dose salidroside group, and a low-dose salidroside group. The contents of ALB, ALP, LDH, PC-III and COL4, and the expression levels of cathepsin B (CB) and NF-κBp65 in the 6 groups were analyzed.â©Results:
Lung coefficient and oxygen partial pressure in the blank group were lower than those in the model group (P<0.05). Compared with the model group, lung coefficients in the pirfenidone group, the high-dose salidroside group, the middle-dose salidroside group, and the low-dose salidroside group were decreased, while oxygen partial pressures were statistically increased (P<0.05). The contents of ALB, ALP and LDH in the model group were statistically increased (P<0.05) in a dose-dependent manner. Compared with the blank group, the contents of GSH, HYP, PC-III and COL4, and the expression levels of CB and NF-κBp65 in the model group were significantly increased (P<0.05), which were attenuated by alidroside in a dose-dependent manner (P<0.05).â©Conclusion:
Salidroside can improve pulmonary fibrosis in rats, and the mechanism may be related to reduce the expression of CB and NF-κBp65.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Fenóis
/
Fibrose Pulmonar
/
Glucosídeos
Tipo de estudo:
Prognostic_studies
Limite:
Animals
Idioma:
Zh
Ano de publicação:
2017
Tipo de documento:
Article